
Dapatyt 10mg Tablet
Marketer
Mitis Biomedics Ltd
Salt Composition
Dapagliflozin (10mg)
Overview Dapatyt 10mg Tablet
Glycemia-10 (10mg tablet) is indicated for managing type 2 diabetes, either independently or as part of a multi-drug regimen. It effectively lowers elevated blood glucose, mitigating the risk of severe diabetic complications and cardiovascular events. Glycemia-10 can be ingested with or without food, consistently at the same time daily, as prescribed by your physician. Discontinuation requires medical consultation, as abrupt cessation may lead to hyperglycemia and potentially serious consequences such as nephropathy and vision impairment. This medication complements a comprehensive diabetes management plan encompassing a balanced diet, physical activity, and weight management as directed by your healthcare provider. Commonly reported adverse effects include vaginal candidiasis, nasopharyngitis, and urinary tract infections; it may also induce diuresis. Adequate hydration is crucial to counter dehydration. Practicing good hygiene can help reduce the incidence of genital fungal infections. Prior to initiating treatment, disclose any pre-existing kidney or liver conditions, urinary tract infections, or diuretic use to your doctor. Pregnant or lactating individuals should seek medical advice before commencing treatment. Limit alcohol consumption during therapy to minimize potential side effects. Regular blood glucose monitoring is essential during treatment.
Primary Ingredients of Dapatyt 10mg Tablet
No text was provided to rewrite.
Uses of Dapatyt 10mg Tablet
Managing type 2 diabetes
Major Benefits of Dapatyt 10mg Tablet:
Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Dapatyt 10mg Tablets can be consumed with or without food, though consistent timing is recommended.
Common Side effects of Dapatyt 10mg Tablet:
- Polyuria
- Nausea
- Vomiting
- Dyslipidemia
- Genital fungal infection
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Urinary tract infection
How to use Dapatyt 10mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dapatyt 10mg tablets can be consumed with or without food, though consistent timing is recommended.
How Dapatyt 10mg Tablet works:
Glycemia control is achieved with the antidiabetic agent, Dapatyt 10mg Tablet, which facilitates urinary excretion of surplus glucose.
SAFETY ADVICE
AlcoholUNSAFE
Combining Dapatyt 10mg Tablet and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Dapatyt 10mg Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Dapatyt 10mg tablets while breastfeeding is likely inadvisable. Available human data indicates a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyUNSAFE
The use of Dapatyt 10mg tablets is likely inadvisable for individuals with kidney impairment and should be omitted. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
Individuals with hepatic impairment can safely use Dapatyt 10mg Tablets without requiring any alteration to the prescribed dosage.
What if you forget to take Dapatyt 10mg Tablet :
Should you forget a Dapatyt 10mg Tablet dose, take it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Dapatyt 10mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Phenolic Glycoside Derivative |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Action Class | Sodium-glucose cotransporter 2 (SGLT2) inhibitors |
